Research and Development

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …

Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …

A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …

UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …

The investment banking industry officially ceased to exist on September 21, 2008. That was the day the last two remaining …

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …

Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …

Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …

US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …

Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …

Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …